We examined two well-known genetic polymorphisms of UGT1A1*28 and MDR1 2677 related to atazanavir-induced hyperbilirubinemia [14], but failed to demonstrate statistically significant correlation between the genetic polymorphisms and incident cholelithiasis and nephrolithiasis. The gene discussed is UGT1A1; the disease is cholelithiasis.